Literature DB >> 21723324

IL-15 and dendritic cells induce proliferation of CD4+CD25+ regulatory T cells from peripheral blood.

Shuxiong Xu1, Zhaolin Sun, Yan Sun, Jianguo Zhu, Xiaowei Li, Xinqi Zhang, Gang Shan, Zhenxing Wang, Hong Liu, Xiongfei Wu.   

Abstract

CD4(+)CD25(+) regulatory T cells (Tregs) have recently been the subject of intense research due to their strong immunosuppressive effect. Increasing evidence suggests that IL-15 plays an important role in Tregs biology. Nevertheless, the mechanism by which IL-15 performs this function remains to be fully elucidated. To address this question, we isolated Tregs from human peripheral blood, and utilized IL-15, dendritic cells (DCs), or DCs combined with IL-15, to examine the proliferation of Tregs and to explore related molecular mechanisms. Here, we show that IL-15 can induce the proliferation of Tregs in the presence of DCs. The induction is mediated by DCs presenting IL-15 in trans to Tregs. Simultaneously, DCs-derived IL-2, regulated by IL-15, may also play a supportive role. After IL-15 withdrawal, IL-15 trans-endosomal recycling in DCs contributes to the proliferation of Tregs. The activation of Akt, Erk1/2 and STAT(5), and the degradation of p27(kip1) may be involved in this process. These findings might explain the proliferation of Tregs in the absence of IL-2 in vivo and provide a novel method to achieve large-scale proliferation of Tregs in vitro in order to obtain cell numbers sufficient for immunotherapy.
Copyright © 2011. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21723324     DOI: 10.1016/j.imlet.2011.06.005

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  6 in total

1.  Interleukin 15 provides relief to CTLs from regulatory T cell-mediated inhibition: implications for adoptive T cell-based therapies for lymphoma.

Authors:  Serena K Perna; Biagio De Angelis; Daria Pagliara; Sayyeda T Hasan; Lan Zhang; Aruna Mahendravada; Helen E Heslop; Malcolm K Brenner; Cliona M Rooney; Gianpietro Dotti; Barbara Savoldo
Journal:  Clin Cancer Res       Date:  2012-11-13       Impact factor: 12.531

2.  CD28-ζ CAR T Cells Resist TGF-β Repression through IL-2 Signaling, Which Can Be Mimicked by an Engineered IL-7 Autocrine Loop.

Authors:  Viktória Golumba-Nagy; Johannes Kuehle; Andreas A Hombach; Hinrich Abken
Journal:  Mol Ther       Date:  2018-07-10       Impact factor: 11.454

3.  IL-15 trans-presentation regulates homeostasis of CD4(+) T lymphocytes.

Authors:  Xi-Lin Chen; Diwakar Bobbala; Yuneivy Cepero Donates; Marian Mayhue; Subburaj Ilangumaran; Sheela Ramanathan
Journal:  Cell Mol Immunol       Date:  2014-03-24       Impact factor: 11.530

4.  IL15 Enhances CAR-T Cell Antitumor Activity by Reducing mTORC1 Activity and Preserving Their Stem Cell Memory Phenotype.

Authors:  Darya Alizadeh; Robyn A Wong; Xin Yang; Dongrui Wang; Joseph R Pecoraro; Cheng-Fu Kuo; Brenda Aguilar; Yue Qi; David K Ann; Renate Starr; Ryan Urak; Xiuli Wang; Stephen J Forman; Christine E Brown
Journal:  Cancer Immunol Res       Date:  2019-03-19       Impact factor: 11.151

Review 5.  The environment of regulatory T cell biology: cytokines, metabolites, and the microbiome.

Authors:  Romy E Hoeppli; Dan Wu; Laura Cook; Megan K Levings
Journal:  Front Immunol       Date:  2015-02-18       Impact factor: 7.561

Review 6.  CAR-T Cells Hit the Tumor Microenvironment: Strategies to Overcome Tumor Escape.

Authors:  Alba Rodriguez-Garcia; Asis Palazon; Estela Noguera-Ortega; Daniel J Powell; Sonia Guedan
Journal:  Front Immunol       Date:  2020-06-17       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.